The weekly litigation news digest is live. Subscribe now

Composition Comprising Epa And Dha For An Enhanced Efficacy Of Anticancer Agents - EP3525781

The patent EP3525781 was granted to Fresenius Kabi Deutschland on Apr 24, 2024. The application was originally filed on Oct 5, 2017 under application number EP17780718A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3525781

FRESENIUS KABI DEUTSCHLAND
Application Number
EP17780718A
Filing Date
Oct 5, 2017
Status
Patent Maintained As Amended
Mar 22, 2024
Publication Date
Apr 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

NUTRICIAOct 27, 2021VO -

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003068385
DESCRIPTIONUS6750048
DESCRIPTIONWO0176385
DESCRIPTIONWO0176715
DESCRIPTIONWO2012028543
INTERNATIONAL-SEARCH-REPORTUS2003068385
INTERNATIONAL-SEARCH-REPORTWO2012028543
OPPOSITIONWO2007075841
OPPOSITIONWO2012033538
OPPOSITIONWO2015113986

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents